| Code | CSB-RA009892MA1HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
Gremlin-1, encoded by the GREM1 gene, functions as a secreted antagonist of bone morphogenetic proteins (BMPs), playing a critical role in developmental signaling, tissue homeostasis, and stem cell regulation. By binding to and inhibiting BMP-2, BMP-4, and BMP-7, Gremlin-1 modulates pathways essential for cell proliferation, differentiation, and survival. Its dysregulation has been implicated in various pathological contexts, including fibrotic diseases and cancer progression, where elevated expression often correlates with tumor growth and metastatic potential. For researchers investigating BMP signaling dynamics, tumor microenvironment interactions, or stem cell biology, reliable detection of Gremlin-1 is fundamental to advancing mechanistic understanding.
This recombinant monoclonal antibody against human GREM1, clone 1D9, offers the consistency and reproducibility that demanding research applications require. Produced using recombinant technology with a defined sequence, this antibody eliminates the lot-to-lot variability inherent in traditional hybridoma-derived reagents, ensuring that your experimental results remain comparable across studies and over time. The human IgG1 isotype format and affinity-chromatography purification yield a high-purity reagent optimized for sensitive detection.
Validated for immunohistochemistry, this antibody has been tested on paraffin-embedded human colon cancer and gastric cancer tissues at 1:100 dilution using citrate buffer antigen retrieval, demonstrating reliable staining in clinically relevant tumor samples. These validation results provide researchers with confidence when examining Gremlin-1 expression patterns in oncology studies or when characterizing its role in gastrointestinal malignancies.
Whether your work focuses on dissecting BMP antagonism in developmental contexts, exploring Gremlin-1 as a potential biomarker in cancer research, or investigating its contributions to stem cell niche regulation, this antibody delivers the specificity and batch consistency needed for meaningful, reproducible results.
There are currently no reviews for this product.